Your browser doesn't support javascript.
loading
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients.
Preijers, T; van Spengler, M W F; Meijer, K; Fijnvandraat, K; Fischer, K; Leebeek, F W G; Cnossen, M H; Mathôt, R A A.
Affiliation
  • Preijers T; Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • van Spengler MWF; Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Meijer K; Department of Pediatric Hematology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.
  • Fijnvandraat K; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Fischer K; Van Creveldkliniek University Medical Center Utrecht, Utrecht, The Netherlands.
  • Leebeek FWG; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Cnossen MH; Department of Pediatric Hematology, Erasmus University Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Mathôt RAA; Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, The Netherlands. r.mathot@amsterdamumc.nl.
Eur J Clin Pharmacol ; 78(2): 237-249, 2022 Feb.
Article in En | MEDLINE | ID: mdl-34651201
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation Factors / Hemophilia B / Drug Monitoring Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Eur J Clin Pharmacol Year: 2022 Document type: Article Affiliation country: Países Bajos Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation Factors / Hemophilia B / Drug Monitoring Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Eur J Clin Pharmacol Year: 2022 Document type: Article Affiliation country: Países Bajos Country of publication: Alemania